Addex Therapeutics Ltd Employee Benefits Expense
Addex Therapeutics Ltd (ADXN) reported Employee Benefits Expense of CHF 44.50 thousand for the 3-month period ending 2025-06-30, per its 6-K filed 2025-09-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:EmployeeBenefitsExpense · last filed 2025-09-30
- Addex Therapeutics Ltd employee benefits expense for the quarter ending 2025-06-30 was 44.50K CHF, a 34.53% decline year-over-year.
- Addex Therapeutics Ltd employee benefits expense for the quarter ending 2024-06-30 was 67.96K CHF, a 95.19% decline year-over-year.
- Addex Therapeutics Ltd employee benefits expense for the quarter ending 2023-06-30 was 1.41M CHF, a 4.43% increase year-over-year.
- Addex Therapeutics Ltd employee benefits expense for the quarter ending 2022-06-30 was 1.35M CHF, a 6.18% increase year-over-year.
| Period end | Employee Benefits Expense 3 month | Employee Benefits Expense 6 month | Employee Benefits Expense 12 month | Employee Benefits Expense 12 month as first filed |
|---|---|---|---|---|
| 2025-06-30 | 44.50K CHF 6-K · filed 2025-09-30 | 145.54K CHF 6-K · filed 2025-09-30 | ||
| 2024-12-31 | 242.59K CHF 20-F · filed 2025-05-15 | |||
| 2024-06-30 | 67.96K CHF 6-K · filed 2025-09-30 | 136.64K CHF 6-K · filed 2025-09-30 | ||
| 2023-12-31 | 238.53K CHF 20-F · filed 2025-05-15 | 5.38M CHF 20-F · filed 2024-04-18 | ||
| 2023-06-30 | 1.41M CHF 6-K/A · filed 2023-12-21 | 2.76M CHF 6-K/A · filed 2023-12-21 | ||
| 2022-12-31 | 253.09K CHF 20-F · filed 2025-05-15 | 7.05M CHF 20-F · filed 2023-03-30 | ||
| 2022-06-30 | 1.35M CHF 6-K/A · filed 2023-12-21 | 3.55M CHF 6-K/A · filed 2023-12-21 | ||
| 2021-12-31 | 4.74M CHF 20-F · filed 2024-04-18 | |||
| 2021-06-30 | 1.27M CHF 6-K/A · filed 2022-09-14 | 2.16M CHF 6-K/A · filed 2022-09-14 | ||
| 2020-12-31 | 4.40M CHF 20-F · filed 2023-03-30 | |||
| 2019-12-31 | 4.29M CHF 20-F · filed 2022-03-10 | |||
| 2018-12-31 | 2.22M CHF 20-F · filed 2021-03-11 | |||
| 2017-12-31 | 751.28K CHF 20-F · filed 2020-04-27 |